Xtrana awarded NIH grant for point-of-care device

Oct. 30, 2002 — Xtrana Inc. has been awarded $986,051 over the next three years from the National Institutes of Health to develop a nucleic acid-based, microfluidic device to detect a panel of respiratory viruses from a single patient sample, the company said in a news release.

Xtrana will collaborate with Micronics Inc. of Redmond, Wash., for lab card and integrated device development, and The Children’s Hospital in Denver for clinical specimens and medical expertise.

The device to be developed is intended to allow physicians, within the course of a typical office visit, to easily and accurately identify a virus present within a patient sample, allowing more effective and rapid treatment, the company’s news release said.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.